Cynthia Seidel Dugan Werewolf Therapeutics, Inc. (HOWL) insider trading activity

HOWL Quotes by TradingView

Cynthia Seidel Dugan is Chief Scientific Officer of Werewolf Therapeutics, Inc.. Currently has a direct ownership of 164,888 shares of HOWL, which is worth approximately $262,171. The most recent transaction as insider was on Jan 12, 2022, when has been sold 39,731 shares (Common Stock) at a price of $3.17 per share, resulting in proceeds of $125,947. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 165K
0% 3M change
0% 12M change
Total Value Held $262,171

Cynthia Seidel-Dugan Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 12 2022
BUY
Exercise of conversion of derivative security
$125,947 $3.17 p/Share
39,731 Added 19.42%
164,888 Common Stock
CS

Cynthia Seidel Dugan

Chief Scientific Officer
Cambridge, MA

Track Institutional and Insider Activities on HOWL

Follow Werewolf Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HOWL shares.

Notify only if

Insider Trading

Get notified when an Werewolf Therapeutics, Inc. insider buys or sells HOWL shares.

Notify only if

News

Receive news related to Werewolf Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on HOWL